Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract

American Journal of Pathology

Volumn 183, Issue 3, 2013, Pages 709-719

  Wang, Yi Wen ^a   Li, Wei Ming ^b   Wu, Wen Jeng ^b,c,d   Chai, Chee Yin ^b   Chang, Tsuey Yu ^a   Sun, Yin ^a   Cheng, Chih Jen ^a   Shiue, Yow Ling ^e   Su, Shu Jem ^f   Cheng, Hong Lin ^a   Liu, Hsiao Sheng ^a   Chow, Nan Haw ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^f FOOYIN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; BIOCHANIN A; CD51 ANTIGEN; DAIDZEIN; EPITHELIAL MEMBRANE PROTEIN 2; GENISTEIN; MEMBRANE PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CARCINOGENICITY; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOGENESIS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; INTEGRINS; ISOFLAVONES; MALE; MEMBRANE GLYCOPROTEINS; MICE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN TRANSPORT; UROLOGIC NEOPLASMS; UROTHELIUM; YOUNG ADULT;

EID: 84883178589     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.05.015     Document Type: Article

References (44)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics CA Cancer J Clin 60 2010 277 300
2. J.J. Munoz, and L.M. Ellison Upper tract urothelial neoplasms: incidence and survival during the last 2 decades J Urol 164 2000 1523 1525
3. M.H. Yang, K.K. Chen, C.C. Yen, W.S. Wang, Y.H. Chang, W.J. Huang, F.S. Fan, T.J. Chiou, J.H. Liu, and P.M. Chen Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan Urology 59 2002 681 687
4. T.F. Chromecki, K. Bensalah, M. Remzi, G. Verhoest, E.K. Cha, D.S. Scherr, G. Novara, P.I. Karakiewicz, and S.F. Shariat Prognostic factors for upper urinary tract urothelial carcinoma Nat Rev Urol 8 2010 440 447
5. G.D. Stewart, S.V. Bariol, K.M. Grigor, D.A. Tolley, and S.A. McNeill A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract BJU Int 95 2005 791 793
6. M. Wadehra, G.G. Sulur, J. Braun, L.K. Gordon, and L. Goodglick Epithelial membrane protein-2 is expressed in discrete anatomical regions of the eye Exp Mol Pathol 74 2003 106 112
7. I. Ben-Porath, C.A. Kozak, and N. Benvenisty Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22 Genomics 49 1998 443 447
8. L.D. Attardi, E.E. Reczek, C. Cosmas, E.G. Demicco, M.E. McCurrach, S.W. Lowe, and T. Jacks PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22/gas3 family Genes Dev 14 2000 704 718
9. C.X. Wang, M. Wadehra, B.C. Fisk, L. Goodglick, and J. Braun Epithelial membrane protein 2, a 4-transmembrane protein that suppresses B-cell lymphoma tumorigenicity Blood 97 2001 3890 3895
10. Y.H. Chen, L.C. Wu, W.R. Wu, H.J. Lin, S.W. Lee, C.Y. Lin, S.L. Chang, N.H. Chow, H.Y. Huang, C.F. Li, H.P. Hsu, and Y.L. Shiue Loss of epithelial membrane protein-2 expression confers an independent prognosticator in nasopharyngeal carcinoma: a cohort study BMJ Open 2 2012 e000900
11. K. Shimazaki, E.J. Lepin, B. Wei, A.K. Nagy, C.P. Coulam, S. Mareninov, M. Fu, A.M. Wu, J.D. Marks, J. Braun, L.K. Gordon, and M. Wadehra Diabodies targeting epithelial membrane protein 2 reduce tumorigenicity of human endometrial cancer cell lines Clin Cancer Res 14 2008 7367 7377
12. M. Fu, E.L. Maresh, R.A. Soslow, M. Alavi, V. Mah, Q. Zhou, A. Iasonos, L. Goodglick, L.K. Gordon, J. Braun, and M. Wadehra Epithelial membrane protein-2 is a novel therapeutic target in ovarian cancer Clin Cancer Res 16 2010 3954 3963
13. O. Habeeb, L. Goodglick, R.A. Soslow, R.G. Rao, L.K. Gordon, O. Schirripa, S. Horvath, J. Braun, D.B. Seligson, and M. Wadehra Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development Cancer 116 2010 4718 4726
14. M. Wadehra, L. Goodglick, and J. Braun The tetraspan protein EMP2 modulates the surface expression of caveolins and glycosylphosphatidyl inositol-linked proteins Mol Biol Cell 15 2004 2073 2083
15. M. Wadehra, S. Natarajan, D.B. Seligson, C.J. Williams, A.J. Hummer, C. Hedvat, J. Braun, and R.A. Soslow Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome Cancer 107 2006 90 98
16. C. Chen, and A.N. Kong Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects Trends Pharmacol Sci 26 2005 318 326
17. S. Banerjee, Y. Li, Z. Wang, and F.H. Sarkar Multi-targeted therapy of cancer by genistein Cancer Lett 269 2008 226 242
18. J.R. Zhou, P. Mukherjee, E.T. Gugger, T. Tanaka, G.L. Blackburn, and S.K. Clinton Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis Cancer Res 58 1998 5231 5238
19. S.J. Su, T.M. Yeh, H.Y. Lei, and N.H. Chow The potential of soybean foods as a chemoprevention approach for human urinary tract cancer Clin Cancer Res 6 2000 230 236
20. S.J. Su, T.M. Yeh, W.J. Chuang, C.L. Ho, K.L. Chang, H.L. Cheng, H.S. Liu, H.L. Cheng, P.Y. Hsu, and N.H. Chow The novel targets for anti-angiogenesis of genistein on human cancer cells Biochem Pharmacol 69 2005 307 318
21. N.H. Chow, Y. Sun, H.S. Liu, S.J. Su, T.M. Yeh, W.J. Chuang, and C.L. Ho Identification of molecular mechanisms of soy isoflavones-induced tumor suppressor effect on human bladder cancer Proc Am Assoc Cancer Res 42 2001 865
22. B.W. Yeh, W.J. Wu, W.M. Li, C.C. Li, C.N. Huang, W.Y. Kang, Z.M. Liu, and H.S. Huang Overexpression of TG-interacting factor is associated with worse prognosis in upper urinary tract urothelial carcinoma Am J Pathol 181 2012 1044 1055
23. L. Cheng, C.X. Pan, X.J. Yang, A. Lopez-Beltran, G.T. MacLennan, H. Lin, T.M. Kuzel, V. Papavero, M. Tretiakova, K. Nigro, M.O. Koch, and J.N. Eble Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients Cancer 101 2004 957 962
24. S.B. Edge, and C.C. Compton The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM Ann Surg Oncol 17 2010 1471 1474
25. H.L. Cheng, B. Trink, T.S. Tzai, H.S. Liu, S.H. Chan, C.L. Ho, D. Sidransky, and N.H. Chow Overexpression of c-met as a prognostic indicator for transitional cell carcinoma of the urinary bladder: a comparison with p53 nuclear accumulation J Clin Oncol 20 2002 1544 1550
26. Y.H. Ju, D.R. Doerge, K.F. Allred, C.D. Allred, and W.G. Helferich Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice Cancer Res 62 2002 2474 2477
27. C.C. Chen, B. Shieh, Y.T. Jin, Y.E. Liau, C.H. Huang, J.T. Liou, L.W. Wu, W. Huang, K.C. Young, M.D. Lai, H.S. Liu, and C. Li Microarray profiling of gene expression patterns in bladder tumor cells treated with genistein J Biomed Sci 8 2001 214 222
28. A.M. Azarova, R.K. Lin, Y.C. Tsai, L.F. Liu, C.P. Lin, and Y.L. Lyu Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: implications in infant leukemia Biochem Biophys Res Commun 399 2010 66 71
29. P.H. Gann, R. Kazer, R. Chatterton, S. Gapstur, K. Thedford, I. Helenowski, S. Giovanazzi, and L. Van Horn Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women Int J Cancer 116 2005 297 303
30. R.L. Vinall, K. Hwa, P. Ghosh, C.X. Pan, P.N. Lara Jr., and R.W. de Vere White Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis Clin Cancer Res 13 2007 6204 6216
31. M. Wadehra, M. Dayal, M. Mainigi, T. Ord, R. Iyer, J. Braun, and C.J. Williams Knockdown of the tetraspan protein epithelial membrane protein-2 inhibits implantation in the mouse Dev Biol 292 2006 430 441
32. C.A. Powell, A. Spira, A. Derti, C. DeLisi, G. Liu, A. Borczuk, S. Busch, S. Sahasrabudhe, Y. Chen, D. Sugarbaker, R. Bueno, W.G. Richards, and J.S. Brody Gene expression in lung adenocarcinomas of smokers and nonsmokers Am J Respir Cell Mol Biol 29 2003 157 162
33. S.A. Tomlins, R. Mehra, D.R. Rhodes, X. Cao, L. Wang, S.M. Dhanasekaran, S. Kalyana-Sundaram, J.T. Wei, M.A. Rubin, K.J. Pienta, R.B. Shah, and A.M. Chinnaiyan Integrative molecular concept modeling of prostate cancer progression Nat Genet 39 2007 41 51
34. D.S. Rickman, M.P. Bobek, D.E. Misek, R. Kuick, M. Blaivas, D.M. Kurnit, J. Taylor, and S.M. Hanash Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis Cancer Res 61 2001 6885 6891
35. K. Obama, K. Ura, M. Li, T. Katagiri, T. Tsunoda, A. Nomura, S. Satoh, Y. Nakamura, and Y. Furukawa Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma Hepatology 41 2005 1339 1348
36. W. Lei, J.J. Rushton, L.M. Davis, F. Liu, and S.A. Ness Positive and negative determinants of target gene specificity in myb transcription factors J Biol Chem 279 2004 29519 29527
37. M.Z. Fang, D. Chen, Y. Sun, Z. Jin, J.K. Christman, and C.S. Yang Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy Clin Cancer Res 11 2005 7033 7041
38. J. Svaren, T. Ehrig, S.A. Abdulkadir, M.U. Ehrengruber, M.A. Watson, and J. Milbrandt EGR1 target genes in prostate carcinoma cells identified by microarray analysis J Biol Chem 275 2000 38524 38531
39. M. Wadehra, A. Forbes, N. Pushkarna, L. Goodglick, L.K. Gordon, C.J. Williams, and J. Braun Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium Dev Biol 287 2005 336 345
40. M. Wadehra, R. Iyer, L. Goodglick, and J. Braun The tetraspan protein epithelial membrane protein-2 interacts with beta1 integrins and regulates adhesion J Biol Chem 277 2002 41094 41100
41. A. Forbes, M. Wadehra, S. Mareninov, S. Morales, K. Shimazaki, L.K. Gordon, and J. Braun The tetraspan protein EMP2 regulates expression of caveolin-1 J Biol Chem 282 2007 26542 26551
42. S. Thomas, J.B. Overdevest, M.D. Nitz, P.D. Williams, C.R. Owens, M. Sanchez-Carbayo, H.F. Frierson, M.A. Schwartz, and D. Theodorescu Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer Cancer Res 71 2011 832 841
43. S.A. Morales, D.G. Telander, S. Mareninov, A. Nagy, M. Wadehra, J. Braun, and L.K. Gordon Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells Exp Eye Res 102 2012 10 16
44. T. Qayyum, G. Fyffe, M. Duncan, P.A. McArdle, M. Hilmy, C. Orange, G. Halbert, M. Seywright, P.G. Horgan, M.A. Underwood, and J. Edwards The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder Br J Cancer 106 2012 1187 1195